4SC-201 (Resminostat) in Advanced Colorectal Carcinoma
NCT01277406
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
17
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Colorectal Carcinoma
Interventions
DRUG:
4SC-201(Resminostat)
DRUG:
FOLFIRI
Sponsor
4SC AG